No insider purchase over the last 90 days. The latest, by 김현정, was filed 04 Aug 2026.
Who traded when
BuySale+5 other insiders
Since the insiders bought
- -16.5%Entry ₩2,180 · Close 30 Oct 2026 ₩1,820
- -42.9%Entry ₩3,190 · Close 30 Oct 2026 ₩1,820
- -42.9%Entry ₩3,190 · Close 30 Oct 2026 ₩1,820
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 300,768 sharesShareKRXDART:20260804000456Canonical exit: 2 Nov 2026 (T+90)
- 300,768 sharesShareKRXDART:20260804000437
- Other0DART
- 23,626 sharesShareKRXDART:20260804000465Canonical exit: 2 Nov 2026 (T+90)
- 300,768 sharesShareKRXDART:20260714000131
- 636,000 sharesShareKRXDART:20260714000130
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 20,000 sharesShareKRXDART:20260630000909Canonical exit: 28 Sept 2026 (T+90)
- ●Executives0DART
- 208,096 sharesKRXDART:20260618000142
- ●Executives0DART
- 14,500 sharesShareKRXDART:20260608000143Canonical exit: 6 Sept 2026 (T+90)
- 10,000 shares@ ₩2,720.500.022% mcap100.0% of flowShareKRXDART:20260420000454Canonical exit: 13 Jul 2026 (T+90)
- 10,000 shares@ ₩2,720.500.022% mcap100.0% of flowShareKRXDART:20260420000447Canonical exit: 13 Jul 2026 (T+90)
- 64,912 shares@ ₩2,720.500.14% mcap100.0% of flowShareKRXDART:20260420000415Canonical exit: 13 Jul 2026 (T+90)
- 8,000 shares@ ₩2,720.500.018% mcap100.0% of flowShareKRXDART:20260420000456Canonical exit: 13 Jul 2026 (T+90)
- 10,000 shares@ ₩2,720.500.022% mcap100.0% of flowShareKRXDART:20260420000451Canonical exit: 13 Jul 2026 (T+90)
- 10,000 shares@ ₩2,720.500.022% mcap100.0% of flowShareKRXDART:20260420000440Canonical exit: 13 Jul 2026 (T+90)
- 24,000 shares@ ₩2,720.500.053% mcap100.0% of flowShareKRXDART:20260420000443Canonical exit: 13 Jul 2026 (T+90)
- 20,000 shares@ ₩2,720.500.044% mcap100.0% of flowShareKRXDART:20260420000437Canonical exit: 13 Jul 2026 (T+90)
- 22,000 shares@ ₩2,720.500.049% mcap100.0% of flowShareKRXDART:20260420000429Canonical exit: 13 Jul 2026 (T+90)
- 0KRXDART:20260417000623
25 of 118 declarations
About T&R Biofab Co., Ltd.
On April 14, 2026, 9 filers at T&R Biofab Co., Ltd. (티앤알바이오팹) bought on the same day, EUR 280,357 in all. The largest purchase is 윤원수's (대표이사), EUR 101,718; 심주성 (부사장, vice president) follows with EUR 37,608, then 심진형 (이사, director) with EUR 34,474. Nine purchases carry an amount, with a median of EUR 15,670.
This Korean health care company, listed on the Korea Exchange at KRW 96.3 billion, has 116 filings published between March 12, 2021 and August 4, 2026. 윤원수 filed 49 (7 purchases, 3 sales); Kb자산운용 (대량보유자, large holder) filed 35, including 3 sales. The market side is 36 purchases against 7 sales, or 84% purchases, and 73 filings are neither. Insiders and declared holders own 14.9% of the capital.
Read moreShow less
The year 2026 already has 37 filings, against 5 in 2024. Over twelve months: 47 filings, 31 purchases and 4 sales. For 21 purchases a 90-day result is stored: a median of minus 18%, with 5% of results positive. These are recorded past results, not a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
